← All organizations
First clinical trial
Jun 1, 2004Last known activity
Apr 28, 2017
Defunct as of Mar 31, 2018
Timeline
2000s
- Jun 1, 2004
Anthera Pharmaceuticals— Founded
2010s
- Mar 31, 2018
Anthera Pharmaceuticals— Defunct
Drugs by trial phase (4 distinct, 26 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Indications
Studied for
- Acute Chest Syndrome
- Acute Coronary Syndrome
- Anemia, Sickle Cell
- Coronary Artery Disease
- Coronary Disease
- Cystic Fibrosis
- Exocrine Pancreatic Insufficiency
- Fibrosis
- Glomerulonephritis, IGA
- Granulomatosis with Polyangiitis
- Kidney Diseases
- Lupus Erythematosus, Systemic
- Microscopic Polyangiitis
- Myocardial Ischemia
- Nephritis
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Renal Insufficiency
- Syndrome
- Systemic Vasculitis
- Vasculitis
Recent trials (27)
- NCT03051490Study directorPhase 3Apr 28, 2017
- NCT03051490Lead sponsorPhase 3Apr 28, 2017
- NCT02823964Lead sponsorPhase 4Sep 1, 2016
- NCT02514967Lead sponsorPhase 3Jun 1, 2016
- NCT02734810Lead sponsorPhase 3Jun 1, 2016
- NCT02074020Lead sponsorPhase 3Dec 1, 2015
- NCT01609452Lead sponsorPhase 2/Phase 3Dec 1, 2015
- NCT02279498Lead sponsorPhase 3Jun 1, 2015
- NCT01598857Lead sponsorPhase 2Dec 1, 2014
- NCT02052219Lead sponsorPhase 3Oct 1, 2014
- NCT02062684Lead sponsorPhase 2/Phase 3Jun 1, 2013
- NCT01395745Lead sponsorPhase 3Feb 1, 2013
- NCT01522196Lead sponsorPhase 2Feb 1, 2012
- NCT01359605Lead sponsorPhase 1Jun 1, 2011
- NCT01359579Lead sponsorPhase 1Jun 1, 2011
Details
- Founded
- Hayward, CA, US Jun 1, 2004
- Last known activity
- Apr 28, 2017